CVS Group’s (CVSG) Outperform Rating Reaffirmed at Royal Bank Of Canada

Royal Bank Of Canada reaffirmed their outperform rating on shares of CVS Group (LON:CVSG) in a research note issued to investors on Thursday, MarketBeat Ratings reports. The brokerage currently has a GBX 1,900 price target on the stock.

Other research analysts have also recently issued reports about the stock. Peel Hunt reissued a “buy” rating and issued a GBX 1,600 price objective on shares of CVS Group in a research note on Tuesday, November 18th. Berenberg Bank reiterated a “buy” rating and issued a GBX 2,000 price target on shares of CVS Group in a research note on Tuesday, November 18th. Four research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of GBX 1,724.

CVS Group Trading Up 0.3%

CVSG opened at GBX 1,282 on Thursday. CVS Group has a twelve month low of GBX 885 and a twelve month high of GBX 1,648. The company has a 50-day simple moving average of GBX 1,338.97 and a 200 day simple moving average of GBX 1,282.91. The company has a quick ratio of 0.90, a current ratio of 1.07 and a debt-to-equity ratio of 121.52. The stock has a market capitalization of £899.40 million, a price-to-earnings ratio of 17.42, a P/E/G ratio of 1.77 and a beta of 1.31.

CVS Group (LON:CVSG) last released its earnings results on Thursday, February 26th. The company reported GBX 40.20 EPS for the quarter. CVS Group had a net margin of 2.31% and a return on equity of 5.35%. Analysts predict that CVS Group will post 93.9393939 EPS for the current fiscal year.

Insider Activity

In other news, insider Richard Gray purchased 2,000 shares of the company’s stock in a transaction dated Monday, January 5th. The stock was bought at an average cost of £1,276.96 per share, for a total transaction of £2,553,920. Company insiders own 1.42% of the company’s stock.

CVS Group Company Profile

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.